Xenon Pharmaceuticals Inc.
XENE
Cena:
$ 53.98
-0.19 (-0.35%)
Valuace
70
Růst
0
Zdraví
75
Akcionáři
Akcionáři společnosti
Insider trading
Akcionáři společnosti
| Držitel | Počet akcií | Podíl společnosti | Změna % | Váha pozice v portfoliu | Prvně nakoupeno |
|---|---|---|---|---|---|
| FMR LLC | 10.8 mil | 13.65% | 0.01% | 0.03% | 2020-03-31 |
| AVORO CAPITAL ADVISORS LLC | 5.8 mil | 7.29% | 0.97% | 3.31% | 2018-06-30 |
| BLACKROCK, INC. | 5.6 mil | 7.12% | 0.00% | 0.01% | 2024-09-30 |
| WELLINGTON MANAGEMENT GROUP LLP | 4.8 mil | 6.09% | 0.02% | 0.05% | 2023-03-31 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 4.5 mil | 5.67% | 0.54% | 1.92% | 2020-03-31 |
| POLAR CAPITAL HOLDINGS PLC | 4.4 mil | 5.56% | 0.48% | 0.91% | 2021-12-31 |
| JANUS HENDERSON GROUP PLC | 4.2 mil | 5.27% | 0.03% | 0.12% | 2022-03-31 |
| CAPITAL INTERNATIONAL INVESTORS | 2.7 mil | 3.37% | 0.01% | 0.04% | 2018-09-30 |
| CITADEL ADVISORS LLC | 2.7 mil | 3.35% | 0.02% | 0.02% | 2018-09-30 |
| BLACKROCK FUNDING, INC. /DE | 2.1 mil | 2.70% | 0.00% | 0.00% | 2024-09-30 |
| BLACKROCK INC. | 2.1 mil | 2.70% | 0.00% | 0.00% | 2018-12-31 |
| PARADIGM BIOCAPITAL ADVISORS LP | 2.0 mil | 2.63% | -0.72% | 3.05% | 2023-03-31 |
| JPMORGAN CHASE & CO | 1.9 mil | 2.43% | 0.00% | 0.01% | 2018-09-30 |
| STATE STREET CORP | 1.7 mil | 2.17% | 0.00% | 0.00% | 2018-09-30 |
| AFFINITY ASSET ADVISORS, LLC | 1.7 mil | 2.11% | 1.84% | 5.03% | 2022-12-31 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1.6 mil | 2.04% | 0.80% | 1.11% | 2025-06-30 |
| HOLOCENE ADVISORS, LP | 1.5 mil | 1.92% | 0.09% | 0.21% | 2025-06-30 |
| ALLIANCEBERNSTEIN L.P. | 1.4 mil | 1.77% | 0.00% | 0.02% | 2021-06-30 |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 1.4 mil | 1.77% | 0.11% | 0.34% | 2023-12-31 |
| CALIGAN PARTNERS LP | 1.4 mil | 1.76% | 3.36% | 5.39% | 2025-09-30 |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 1.3 mil | 1.69% | 0.04% | 0.09% | 2024-03-31 |
| BRAIDWELL LP | 1.3 mil | 1.69% | -0.02% | 2.60% | 2022-12-31 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.3 mil | 1.68% | 0.00% | 0.01% | 2025-06-30 |
| JENNISON ASSOCIATES LLC | 1.3 mil | 1.66% | 0.02% | 0.05% | 2023-06-30 |
| SIREN, L.L.C. | 1.3 mil | 1.66% | 1.04% | 2.13% | 2024-09-30 |
| ALYESKA INVESTMENT GROUP, L.P. | 1.3 mil | 1.64% | 0.21% | 0.21% | 2026-03-31 |
| FRANKLIN RESOURCES INC | 1.3 mil | 1.62% | 0.01% | 0.02% | 2023-03-31 |
| DEEP TRACK CAPITAL, LP | 1.2 mil | 1.52% | -0.01% | 1.34% | 2024-12-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.1 mil | 1.38% | 0.00% | 0.00% | 2018-12-31 |
| BVF INC/IL | 890.07 tis | 1.35% | -0.66% | 1.03% | 2014-12-31 |
| ORBIMED ADVISORS LLC | 1.1 mil | 1.34% | 0.82% | 1.23% | 2016-09-30 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1.1 mil | 1.33% | 0.01% | 0.01% | 2025-06-30 |
| SAMLYN CAPITAL, LLC | 1.0 mil | 1.29% | -0.10% | 0.51% | 2021-12-31 |
| CAPTION MANAGEMENT, LLC | 982.20 tis | 1.24% | 0.24% | 0.33% | 2025-03-31 |
| FEDERATED HERMES, INC. | 972.24 tis | 1.23% | 0.04% | 0.09% | 2023-12-31 |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 951.96 tis | 1.20% | 0.02% | 0.04% | 2023-12-31 |
| INVESCO LTD. | 866.79 tis | 1.12% | 0.00% | 0.01% | 2023-03-31 |
| CAPITAL WORLD INVESTORS | 840.07 tis | 1.06% | 0.00% | 0.01% | 2014-12-31 |
| COMMODORE CAPITAL LP | 825.00 tis | 1.04% | -2.59% | 2.78% | 2020-12-31 |
| FIRST TURN MANAGEMENT, LLC | 786.84 tis | 0.99% | 1.02% | 5.11% | 2023-12-31 |
| GOLDMAN SACHS GROUP INC | 769.88 tis | 0.97% | 0.00% | 0.01% | 2018-12-31 |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 763.02 tis | 0.96% | 0.80% | 2.62% | 2020-03-31 |
| FIERA CAPITAL CORP | 709.53 tis | 0.90% | 0.04% | 0.14% | 2023-06-30 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 685.10 tis | 0.86% | -0.01% | 0.05% | 2018-06-30 |
| PICTET ASSET MANAGEMENT HOLDING SA | 679.71 tis | 0.86% | 0.01% | 0.04% | 2023-09-30 |
| AMERICAN CENTURY COMPANIES INC | 679.31 tis | 0.86% | 0.01% | 0.02% | 2025-06-30 |
| VANGUARD GROUP INC | 664.64 tis | 0.84% | 0.00% | 0.00% | 2020-06-30 |
| LOGOS GLOBAL MANAGEMENT LP | 650.00 tis | 0.83% | 3.88% | 3.88% | 2025-03-31 |
| VESTAL POINT CAPITAL, LP | 639.90 tis | 0.81% | 0.13% | 1.04% | 2023-12-31 |
| MILLENNIUM MANAGEMENT LLC | 635.06 tis | 0.80% | -0.01% | 0.01% | 2019-12-31 |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 627.90 tis | 0.80% | -1.95% | 2.41% | 2023-03-31 |
| MARSHALL WACE, LLP | 611.98 tis | 0.78% | -0.01% | 0.02% | 2021-06-30 |
| BOXER CAPITAL, LLC | 600.00 tis | 0.77% | -0.07% | 1.16% | 2021-06-30 |
| ABRDN PLC | 609.93 tis | 0.77% | 0.01% | 0.06% | 2023-12-31 |
| TWO SIGMA INVESTMENTS, LP | 606.09 tis | 0.76% | 0.00% | 0.03% | 2025-12-31 |
| BARCLAYS PLC | 600.96 tis | 0.76% | 0.01% | 0.01% | 2023-03-31 |
| BIOIMPACT CAPITAL LLC | 588.71 tis | 0.74% | 0.15% | 2.64% | 2024-09-30 |
| LOOMIS SAYLES & CO L P | 564.90 tis | 0.71% | 0.01% | 0.04% | 2022-12-31 |
| 543.06 tis | 0.69% | 0.00% | 0.00% | 2026-03-31 | |
| TIMESSQUARE CAPITAL MANAGEMENT, LLC | 532.74 tis | 0.67% | 0.04% | 0.36% | 2022-12-31 |
| NORTHERN TRUST CORP | 527.78 tis | 0.67% | 0.00% | 0.00% | 2018-09-30 |
| SATURN V CAPITAL MANAGEMENT LLC | 503.70 tis | 0.64% | -1.51% | 4.44% | 2024-12-31 |
| PARKMAN HEALTHCARE PARTNERS LLC | 497.04 tis | 0.63% | 2.32% | 2.98% | 2019-12-31 |
| TUDOR INVESTMENT CORP ET AL | 495.59 tis | 0.63% | 0.03% | 0.05% | 2025-09-30 |
| OCTAGON CAPITAL ADVISORS LP | 490.00 tis | 0.62% | 3.15% | 3.15% | 2026-03-31 |
| NOVO HOLDINGS A/S | 485.44 tis | 0.61% | 2.29% | 2.29% | 2026-03-31 |
| AVIDITY PARTNERS MANAGEMENT LP | 474.00 tis | 0.61% | 0.18% | 1.82% | 2023-06-30 |
| CANDRIAM S.C.A. | 476.49 tis | 0.60% | 0.05% | 0.14% | 2021-06-30 |
| DIMENSIONAL FUND ADVISORS LP | 452.15 tis | 0.57% | 0.00% | 0.00% | 2021-06-30 |
| ASSENAGON ASSET MANAGEMENT S.A. | 436.97 tis | 0.56% | 0.01% | 0.02% | 2023-09-30 |
| BANK OF NEW YORK MELLON CORP | 418.42 tis | 0.53% | 0.00% | 0.00% | 2019-06-30 |
| UBS ASSET MANAGEMENT AMERICAS INC | 404.38 tis | 0.51% | 0.00% | 0.00% | 2020-06-30 |
| POINT72 ASSET MANAGEMENT, L.P. | 383.29 tis | 0.49% | -0.01% | 0.04% | 2015-03-31 |
| ARTAL GROUP S.A. | 381.55 tis | 0.49% | 0.10% | 0.38% | 2024-03-31 |
| BAKER BROS. ADVISORS LP | 370.21 tis | 0.47% | -0.01% | 0.11% | 2020-06-30 |
| MORGAN STANLEY | 366.57 tis | 0.46% | 0.00% | 0.00% | 2015-03-31 |
| BANK OF AMERICA CORP /DE/ | 358.43 tis | 0.46% | 0.00% | 0.00% | 2019-12-31 |
| PERCEPTIVE ADVISORS LLC | 325.32 tis | 0.41% | 0.03% | 0.38% | 2021-03-31 |
| ALLY BRIDGE GROUP (NY) LLC | 309.37 tis | 0.40% | 0.76% | 7.40% | 2023-03-31 |
| TWO SIGMA ADVISERS, LP | 298.80 tis | 0.38% | 0.00% | 0.02% | 2023-09-30 |
| ALTIUM CAPITAL MANAGEMENT LP | 288.00 tis | 0.37% | -0.98% | 3.20% | 2023-06-30 |
| DAFNA CAPITAL MANAGEMENT LLC | 287.94 tis | 0.37% | -0.12% | 2.49% | 2015-09-30 |
| STEMPOINT CAPITAL LP | 274.63 tis | 0.35% | -0.74% | 2.94% | 2024-12-31 |
| BALYASNY ASSET MANAGEMENT L.P. | 267.14 tis | 0.34% | 0.00% | 0.01% | 2023-12-31 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 262.63 tis | 0.34% | -0.03% | 0.06% | 2023-03-31 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 259.50 tis | 0.33% | 0.45% | 1.25% | 2024-06-30 |
| BOONE CAPITAL MANAGEMENT LLC | 250.46 tis | 0.32% | 0.01% | 2.55% | 2023-12-31 |
| GREAT POINT PARTNERS LLC | 245.27 tis | 0.31% | -0.17% | 4.36% | 2024-12-31 |
| TRI LOCUM PARTNERS LP | 207.47 tis | 0.31% | -1.65% | 3.10% | 2021-09-30 |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 240.04 tis | 0.31% | 0.00% | 0.31% | 2019-03-31 |
| ALGERT GLOBAL LLC | 184.02 tis | 0.28% | -0.09% | 0.31% | 2022-03-31 |
| NICHOLAS INVESTMENT PARTNERS, LP | 167.93 tis | 0.25% | 0.27% | 0.74% | 2022-12-31 |
| LORD, ABBETT & CO. LLC | 190.03 tis | 0.24% | -0.10% | 0.02% | 2021-03-31 |
| AXA S.A. | 188.04 tis | 0.24% | 0.00% | 0.02% | 2021-09-30 |
| DNB ASSET MANAGEMENT AS | 175.73 tis | 0.23% | 0.00% | 0.03% | 2022-12-31 |
| ENSIGN PEAK ADVISORS, INC | 163.06 tis | 0.21% | 0.00% | 0.01% | 2021-09-30 |
| RUSSELL INVESTMENTS GROUP, LTD. | 162.85 tis | 0.21% | 0.00% | 0.01% | 2021-12-31 |
| D. E. SHAW & CO., INC. | 161.72 tis | 0.21% | 0.00% | 0.01% | 2018-12-31 |
| NEW YORK STATE COMMON RETIREMENT FUND | 150.84 tis | 0.19% | 0.00% | 0.01% | 2021-12-31 |
| SWISS NATIONAL BANK | 126.10 tis | 0.16% | 0.00% | 0.00% | 2020-06-30 |
| ATIKA CAPITAL MANAGEMENT LLC | 124.00 tis | 0.16% | -0.04% | 0.47% | 2023-03-31 |
| BAMCO INC /NY/ | 100.10 tis | 0.13% | 0.00% | 0.01% | 2021-12-31 |
| RENAISSANCE TECHNOLOGIES LLC | 92.90 tis | 0.12% | 0.00% | 0.01% | 2023-09-30 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 91.50 tis | 0.12% | 0.00% | 0.00% | 2023-12-31 |
| STATE OF WISCONSIN INVESTMENT BOARD | 89.80 tis | 0.12% | 0.00% | 0.01% | 2022-03-31 |
| JEFFERIES FINANCIAL GROUP INC. | 69.00 tis | 0.09% | 0.00% | 0.03% | 2022-12-31 |
| LEGAL & GENERAL GROUP PLC | 60.53 tis | 0.08% | 0.00% | 0.00% | 2020-06-30 |
| WELLS FARGO & COMPANY/MN | 59.07 tis | 0.08% | 0.00% | 0.00% | 2022-09-30 |
| ALPS ADVISORS INC | 58.85 tis | 0.08% | 0.00% | 0.02% | 2020-06-30 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 58.14 tis | 0.07% | 0.00% | 0.00% | 2021-09-30 |
| DEUTSCHE BANK AG\ | 53.71 tis | 0.07% | 0.00% | 0.00% | 2022-12-31 |
Insider trading
| Jméno | Pozice | Typ transakce | Počet převedených akcií | Průměrná cena akcie | Datum | Počet držených akcií |
|---|---|---|---|---|---|---|
| GANNON STEVEN | director | M-Exempt | 3500 | 7.38 | 13.5 2026 | 0 |
| GANNON STEVEN | director | M-Exempt | 3500 | 7.38 | 13.5 2026 | 10641 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | S-Sale | 7308 | 55.23 | 13.3 2026 | 19923 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | M-Exempt | 12500 | 0.00 | 13.3 2026 | 27231 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | M-Exempt | 12500 | 0.00 | 13.3 2026 | 37500 |
| DiFabio Andrea | officer: Chief Legal Officer | S-Sale | 1342 | 55.23 | 13.3 2026 | 7301 |
| DiFabio Andrea | officer: Chief Legal Officer | M-Exempt | 3750 | 0.00 | 13.3 2026 | 8643 |
| DiFabio Andrea | officer: Chief Legal Officer | M-Exempt | 3750 | 0.00 | 13.3 2026 | 11250 |
| KENNEY CHRISTOPHER JOHN | officer: Chief Medical Officer | S-Sale | 1410 | 55.23 | 13.3 2026 | 7069 |
| KENNEY CHRISTOPHER JOHN | officer: Chief Medical Officer | M-Exempt | 3750 | 0.00 | 13.3 2026 | 8479 |
| KENNEY CHRISTOPHER JOHN | officer: Chief Medical Officer | M-Exempt | 3750 | 0.00 | 13.3 2026 | 11250 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | M-Exempt | 65000 | 9.44 | 11.3 2026 | 0 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | M-Exempt | 105000 | 4.75 | 11.3 2026 | 0 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | M-Exempt | 25000 | 3.10 | 11.3 2026 | 0 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | M-Exempt | 75000 | 8.40 | 11.3 2026 | 0 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | M-Exempt | 20000 | 0.00 | 11.3 2026 | 0 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | S-Sale | 21515 | 60.49 | 11.3 2026 | 6000 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | S-Sale | 61652 | 60.08 | 11.3 2026 | 6000 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | S-Sale | 2449 | 61.26 | 11.3 2026 | 6000 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | S-Sale | 65000 | 62.06 | 11.3 2026 | 6000 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | S-Sale | 10072 | 60.47 | 11.3 2026 | 8449 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | S-Sale | 11269 | 60.11 | 11.3 2026 | 14731 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | S-Sale | 12479 | 59.50 | 11.3 2026 | 18521 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | A-Award | 20000 | 0.00 | 11.3 2026 | 20000 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | M-Exempt | 20000 | 0.00 | 11.3 2026 | 26000 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | S-Sale | 31694 | 59.88 | 11.3 2026 | 27515 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | M-Exempt | 25000 | 3.10 | 11.3 2026 | 31000 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | S-Sale | 21791 | 58.81 | 11.3 2026 | 59209 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | M-Exempt | 65000 | 9.44 | 11.3 2026 | 71000 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | S-Sale | 43348 | 59.26 | 11.3 2026 | 72652 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | M-Exempt | 75000 | 8.40 | 11.3 2026 | 81000 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | M-Exempt | 105000 | 4.75 | 11.3 2026 | 111000 |
| DiFabio Andrea | officer: Chief Legal Officer | M-Exempt | 7500 | 0.00 | 11.3 2026 | 0 |
| DiFabio Andrea | officer: Chief Legal Officer | S-Sale | 2607 | 60.11 | 11.3 2026 | 4893 |
| DiFabio Andrea | officer: Chief Legal Officer | A-Award | 7500 | 0.00 | 11.3 2026 | 7500 |
| DiFabio Andrea | officer: Chief Legal Officer | M-Exempt | 7500 | 0.00 | 11.3 2026 | 7500 |
| KENNEY CHRISTOPHER JOHN | officer: Chief Medical Officer | M-Exempt | 7500 | 0.00 | 11.3 2026 | 0 |
| KENNEY CHRISTOPHER JOHN | officer: Chief Medical Officer | S-Sale | 2771 | 60.11 | 11.3 2026 | 4729 |
| KENNEY CHRISTOPHER JOHN | officer: Chief Medical Officer | A-Award | 7500 | 0.00 | 11.3 2026 | 7500 |
| KENNEY CHRISTOPHER JOHN | officer: Chief Medical Officer | M-Exempt | 7500 | 0.00 | 11.3 2026 | 7500 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | A-Award | 65000 | 0.00 | 9.1 2026 | 65000 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | A-Award | 350000 | 42.15 | 9.1 2026 | 350000 |
| DiFabio Andrea | officer: Chief Legal Officer | A-Award | 15000 | 0.00 | 9.1 2026 | 15000 |
| DiFabio Andrea | officer: Chief Legal Officer | A-Award | 80000 | 42.15 | 9.1 2026 | 80000 |
| Cline Darren S | officer: Chief Commercial Officer | A-Award | 20000 | 0.00 | 9.1 2026 | 20000 |
| Cline Darren S | officer: Chief Commercial Officer | A-Award | 40000 | 42.15 | 9.1 2026 | 40000 |
| KENNEY CHRISTOPHER JOHN | officer: Chief Medical Officer | A-Award | 20000 | 0.00 | 9.1 2026 | 20000 |
| KENNEY CHRISTOPHER JOHN | officer: Chief Medical Officer | A-Award | 100000 | 42.15 | 9.1 2026 | 100000 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | M-Exempt | 40000 | 7.49 | 2.1 2026 | 0 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | S-Sale | 2062 | 44.93 | 2.1 2026 | 6000 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | S-Sale | 37938 | 44.40 | 2.1 2026 | 8062 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | M-Exempt | 40000 | 7.49 | 2.1 2026 | 46000 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | S-Sale | 2010 | 46.32 | 9.12 2025 | 6000 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | S-Sale | 8820 | 45.59 | 9.12 2025 | 8010 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | S-Sale | 14375 | 45.03 | 9.12 2025 | 16830 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | S-Sale | 97 | 45.01 | 3.12 2025 | 31205 |
| Kelly Thomas Patrick | officer: Chief Financial Officer | 0 | 0.00 | 17.10 2025 | 0 | |
| Kelly Thomas Patrick | officer: Chief Financial Officer | A-Award | 30000 | 0.00 | 17.10 2025 | 30000 |
| Kelly Thomas Patrick | officer: Chief Financial Officer | A-Award | 225000 | 41.90 | 17.10 2025 | 225000 |
| MORTIMER IAN | director, officer: PRESIDENT, CEO & INTERIM CFO | M-Exempt | 25000 | 7.69 | 1.10 2025 | 0 |
| MORTIMER IAN | director, officer: PRESIDENT, CEO & INTERIM CFO | S-Sale | 25000 | 40.16 | 1.10 2025 | 31302 |
| MORTIMER IAN | director, officer: PRESIDENT, CEO & INTERIM CFO | M-Exempt | 25000 | 7.69 | 1.10 2025 | 56302 |
| Cline Darren S | officer: Chief Commercial Officer | 0 | 0.00 | 24.6 2025 | 0 | |
| Cline Darren S | officer: Chief Commercial Officer | A-Award | 185800 | 31.49 | 24.6 2025 | 185800 |
| Svoronos Dawn | director | A-Award | 2645 | 0.00 | 6.6 2025 | 2645 |
| Svoronos Dawn | director | A-Award | 17012 | 30.73 | 6.6 2025 | 17012 |
| Cannon Gillian | director | A-Award | 2645 | 0.00 | 6.6 2025 | 2645 |
| Cannon Gillian | director | A-Award | 17012 | 30.73 | 6.6 2025 | 17012 |
| GANNON STEVEN | director | A-Award | 2645 | 0.00 | 6.6 2025 | 2645 |
| GANNON STEVEN | director | S-Sale | 3 | 30.48 | 6.6 2025 | 7141 |
| GANNON STEVEN | director | A-Award | 17012 | 30.73 | 6.6 2025 | 17012 |
| GAROFALO ELIZABETH A. | director | A-Award | 2645 | 0.00 | 6.6 2025 | 2645 |
| GAROFALO ELIZABETH A. | director | A-Award | 17012 | 30.73 | 6.6 2025 | 17012 |
| Gover Justin D. | director | A-Award | 2645 | 0.00 | 6.6 2025 | 2645 |
| Gover Justin D. | director | A-Award | 17012 | 30.73 | 6.6 2025 | 17012 |
| Machado Patrick | director | A-Award | 2645 | 0.00 | 6.6 2025 | 2645 |
| Machado Patrick | director | A-Award | 17012 | 30.73 | 6.6 2025 | 17012 |
| PATOU GARY | director | A-Award | 2645 | 0.00 | 6.6 2025 | 2645 |
| PATOU GARY | director | A-Award | 17012 | 30.73 | 6.6 2025 | 17012 |
| GANNON STEVEN | director | M-Exempt | 5144 | 12.57 | 16.5 2025 | 0 |
| GANNON STEVEN | director | M-Exempt | 5144 | 12.57 | 16.5 2025 | 7144 |
| DiFabio Andrea | officer: Chief Legal Officer | A-Award | 15000 | 0.00 | 13.3 2025 | 15000 |
| DiFabio Andrea | officer: Chief Legal Officer | A-Award | 80000 | 35.48 | 13.3 2025 | 80000 |
| KENNEY CHRISTOPHER JOHN | officer: Chief Medical Officer | A-Award | 15000 | 0.00 | 13.3 2025 | 15000 |
| KENNEY CHRISTOPHER JOHN | officer: Chief Medical Officer | A-Award | 80000 | 35.48 | 13.3 2025 | 80000 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | A-Award | 50000 | 0.00 | 13.3 2025 | 50000 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | A-Award | 275000 | 35.48 | 13.3 2025 | 275000 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | M-Exempt | 16315 | 17.76 | 27.1 2025 | 0 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | M-Exempt | 22468 | 17.76 | 27.1 2025 | 16315 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | S-Sale | 16217 | 40.08 | 27.1 2025 | 31302 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | S-Sale | 1149 | 41.07 | 27.1 2025 | 31302 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | S-Sale | 22468 | 40.20 | 27.1 2025 | 31302 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | S-Sale | 15166 | 40.46 | 27.1 2025 | 31302 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | M-Exempt | 1149 | 17.76 | 27.1 2025 | 32451 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | M-Exempt | 16217 | 17.76 | 27.1 2025 | 38783 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | M-Exempt | 15166 | 17.76 | 27.1 2025 | 46468 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | M-Exempt | 16217 | 17.76 | 27.1 2025 | 47519 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | M-Exempt | 22468 | 17.76 | 27.1 2025 | 53770 |
| AULIN SHERRY | officer: Chief Financial Officer | F-InKind | 4490 | 41.28 | 19.12 2024 | 11510 |
| AULIN SHERRY | officer: Chief Financial Officer | M-Exempt | 16000 | 11.58 | 19.12 2024 | 16000 |
